At Passage Bio, our mission is to improve the lives of patients with neurodegenerative diseases by delivering genetic medicines that will permanently redefine the course of their conditions.

Our approach involves developing cutting-edge, one-time treatments that can alter the course of neurodegenerative diseases and are underpinned by rigorous scientific research and state-of-the-art CMC analytics. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative diseases.

A bold vision to fulfill the promise of gene therapy by delivering life-transforming medicines that provide a cure for previously incurable diseases.